-+ 0.00%
-+ 0.00%
-+ 0.00%
Market One Minute Feature on BNN Bloomberg: MustGrow Biologics and Bayer AG Discusses Validation of Its TerraMG Biocontrol Technology
Share
Listen to the news

Vancouver, British Columbia--(Newsfile Corp. - October 29, 2026) - Market One ("Market One"), a marketing agency for public companies, shares editorial and video features on emerging growth stories across the resource, energy, and technology sectors.

Market One delivers content creation and distribution through a suite of products across video, editorial, and social media.

MustGrow Biologics Corp.: Advancing Its TerraMG™ Biocontrol Partnership with Bayer AG

MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") and Bayer AG discuss their License and Collaboration agreement covering Europe, the Middle East, and Africa, including field trials confirming TerraMG™'s control of soil-borne diseases, its compatibility with European application equipment, and receipt of a first milestone payment.

The article and accompanying video examines how Bayer's nearly two-year evaluation and subsequent agreement are advancing MustGrow's mustard-derived biocontrol technology, against the backdrop of tightening European regulation on synthetic pesticides and fertilizers and growing demand for biological crop inputs.



Cannot view this video? Visit:
https://www.youtube.com/watch?v=R7m7VUmZYAo

To read the full article, please visit BNN Bloomberg at: https://www.bnnbloomberg.ca/investment-trends/2026/10/29/mustgrow-and-bayer-advance-mustard-based-biocontrol-in-europe-the-middle-east-and-africa/

About MustGrow Biologics Corp.

MustGrow Biologics is a Saskatchewan-based agriculture biotechnology company commercializing mustard seed-derived biological solutions — including TerraMG™ soil biocontrol and TerraSante™ biofertility — backed by approximately 110 issued and pending patents. The company pursues a capital-efficient licensing model, partnering with global crop science leaders such as Bayer, which holds exclusive rights across Europe, the Middle East, and Africa under an agreement valued at approximately USD $35-40 million before royalties and manufacturing sales.

Learn more at mustgrow.ca.
Follow MustGrow Biologics on LinkedIn, Facebook, X, and YouTube.

Contact:
Corey Giasson, Director & CEO
Phone: 1-306-668-2652
Email: info@mustgrow.ca

About Market One

Market One is a Canadian marketing agency for public companies, delivering best-in-class content creation and distribution. The firm helps position companies for meaningful engagement through a suite of products across video, editorial, and social media. Clients benefit from increased visibility and strengthened awareness through Market One's content and relationships with industry-leading media outlets.

Learn more at marketone.ca.

Contact:
Bryan Nikkel
Phone: 778-836-0109
Email: bryan@marketone.ca

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/321626

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending